文献速递眼底病与葡萄膜炎

年龄相关性黄斑变性患者的粪便微生物特征及短链脂肪酸/胆汁酸代谢组学:一项先导研究

Fecal Microbial Profiles and Short-Chain Fatty Acid/Bile Acid Metabolomics in Patients With Age-Related Macular Degeneration: A Pilot Study.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

这项先导研究分析了22例来自三级学术中心的空腹粪便样本,受试者按临床表现分为对照组、中期年龄相关性黄斑变性(AMD)和晚期AMD,采用16S rRNA扩增子测序和色谱-质谱法检测细菌分类组成及短链脂肪酸(SCFAs)和胆汁酸(BAs)丰度,并对AMD队列进行14个高危单核苷酸多态性(SNPs)检测。结果发现三组间有43个差异丰度菌属,晚期AMD患者中Desulfovibrionales(q=0.10)和Terrisporobacter(q=1.16e-03)丰度高于中期AMD,且晚期AMD患者12种SCFAs(包括乙酸盐P=0.002、丁酸盐P=0.04、丙酸盐P=0.01)和12种BAs(包括牛磺胆酸P=0.02、牛磺熊去氧胆酸P=0.04)丰度降低;中期与晚期AMD组间高危SNPs频率无显著差异。作者结论认为该先导研究识别出与AMD及其分期相关的独特肠道微生物组组成和代谢组学特征,为肠道微生物群与AMD发病机制之间的潜在联系提供了初步证据,并强烈建议未来开展更大队列和更全面采样的研究以验证这些发现并阐明潜在机制。

要点

  • 三组间存在43个差异丰度菌属,晚期AMD患者Desulfovibrionales(q=0.10)和Terrisporobacter(q=1.16e-03)丰度高于中期AMD患者。
  • 晚期AMD患者12种SCFAs丰度降低,包括乙酸盐(P=0.002)、丁酸盐(P=0.04)和丙酸盐(P=0.01)。
  • 晚期AMD患者12种BAs丰度降低,包括牛磺胆酸(P=0.02)和牛磺熊去氧胆酸(P=0.04);中期与晚期AMD组间高危SNPs频率无显著差异。

核心结论

  • 这项先导研究识别出与AMD及其分期相关的独特肠道微生物组组成和代谢组学特征,为肠道微生物群与AMD发病机制之间的潜在联系提供了初步证据。
  • 作者强烈建议未来开展更大队列和更全面采样的研究以验证这些发现并阐明潜在机制。

研究设计与样本

  • 先导研究,分析来自三级学术中心的22例患者空腹粪便样本。
  • 受试者根据临床表现分为对照组、中期AMD组或晚期AMD组。
  • 采用16S rRNA扩增子测序鉴定细菌分类组成,采用标准色谱-质谱法检测短链脂肪酸(SCFAs)和胆汁酸(BAs)丰度。
  • 对AMD队列进行基因检测,调查14个与AMD相关的高危单核苷酸多态性(SNPs)的频率。

主要发现

  • 对照组、中期AMD组和晚期AMD组之间存在43个差异丰度菌属。
  • 在免疫通路中已知作用的分类群如Desulfovibrionales(q=0.10)和Terrisporobacter(q=1.16e-03)在晚期AMD患者中的丰度高于中期AMD患者。
  • 晚期AMD患者12种SCFAs丰度降低,包括乙酸盐(P=0.002)、丁酸盐(P=0.04)和丙酸盐(P=0.01)。
  • 晚期AMD患者12种BAs丰度降低,包括牛磺胆酸(P=0.02)和牛磺熊去氧胆酸(P=0.04)。
  • 高危SNPs频率在中期AMD组与晚期AMD组之间无显著差异。

局限性

  • 作者强烈建议未来开展更大队列和更全面采样的研究以验证这些发现并阐明潜在机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Age-related macular degeneration (AMD) is a multifactorial disease, and studies have implicated the role of gut microbiota in its pathogenesis. However, characterization of microbiome dysbiosis and associated microbial-derived metabolomic profiles across AMD stages remains unknown. In this pilot study, we explored how gut microbiome composition and gut-derived metabolites differ in AMD. METHODS: Our pilot study analyzed fasted stool samples that were collected from 22 patients at a tertiary academic center. Subjects were classified as control, intermediate AMD, or advanced AMD based on clinical presentation. 16S rRNA amplicon sequencing and standard chromatography-mass spectrometry methods were used to identify bacterial taxonomy composition and abundance of short-chain fatty acids (SCFAs) and bile acids (BAs), respectively. Genetic testing was used to investigate the frequency of 14 high-risk single nucleotide polymorphisms (SNPs) associated with AMD in the AMD cohort. RESULTS: Forty-three differentially abundant genera were present among the control, intermediate, and advanced groups. Taxa with known roles in immunologic pathways, such as Desulfovibrionales (q = 0.10) and Terrisporobacter (q = 1.16e-03), were in greater abundance in advanced AMD patients compared to intermediate. Advanced AMD patients had decreased abundance of 12 SCFAs, including acetate (P = 0.002), butyrate (P = 0.04), and propionate (P = 0.01), along with 12 BAs, including taurocholic acid (P = 0.02) and tauroursodeoxycholic acid (P = 0.04). Frequencies of high-risk SNPs were not significantly different between the intermediate and advanced AMD groups. CONCLUSIONS: This pilot study identifies distinct gut microbiome compositions and metabolomic profiles associated with AMD and its stages, providing preliminary evidence of a potential link between gut microbiota and AMD pathogenesis. To validate these findings and elucidate the underlying mechanisms, future research with larger cohorts and more comprehensive sampling is strongly recommended.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Parekh Z, Xiao J, Mani A, et al. Fecal Microbial Profiles and Short-Chain Fatty Acid/Bile Acid Metabolomics in Patients With Age-Related Macular Degeneration: A Pilot Study. Invest Ophthalmol Vis Sci. 2025. PMID: 40202735. doi:10.1167/iovs.66.4.21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。